Fulgent Genetics (MEX:FLGT) Beta: 0.3621 (As of Jun. 25, 2026)


MEX:FLGT Fulgent Genetics Inc MEX:FLGT
64 GF Score
Price MXN312.50
GF Value MXN729.64
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Fulgent Genetics Beta?

Fulgent Genetics MEX:FLGT 64 Beta is 0.3621 as of Jun. 25, 2026. GuruFocus rates MEX:FLGT with a GF Score™ of 64/100 and a GF Value™ of MXN729.64 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Fulgent Genetics's Beta is 0.3621.


Fulgent Genetics  (MEX:FLGT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Fulgent Genetics Beta Related Terms


Fulgent Genetics Beta Historical Data

* Premium members only.

The historical data trend for Fulgent Genetics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fulgent Genetics Beta Chart

Fulgent Genetics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.49 -0.06 -0.34

Fulgent Genetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.07 -0.22 -0.34 0.05

MEX:FLGT vs CSTL, MYGN, PRE: Beta Comparison

For the Diagnostics & Research subindustry, Fulgent Genetics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fulgent Genetics Beta vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Beta distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's Beta falls into.


MEX:FLGT
64GF Score
Fulgent Genetics Inc MEX:FLGT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fulgent Genetics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.3621 mean?
Fulgent Genetics (MEX:FLGT) has a Beta of 0.3621 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fulgent Genetics and its competitors.
Is Fulgent Genetics' Beta too high?
Fulgent Genetics' current Beta is 0.3621. Overall, Fulgent Genetics has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fulgent Genetics' Beta compare to CSTL and MYGN?
Fulgent Genetics' Beta of 0.3621 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Diagnostics & Research company?
A good Beta depends on the Medical Diagnostics & Research industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fulgent Genetics and its competitors. Fulgent Genetics's current Beta is 0.3621. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fulgent Genetics stock overvalued right now?
Based on GuruFocus' analysis, Fulgent Genetics (MEX:FLGT) is currently considered Possible Value Trap. The stock's GF Value™ is MXN729.64, compared to a current price of MXN312.50 — trading 57.2% below its estimated fair value. The current Beta is 0.3621. Fulgent Genetics' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Fulgent Genetics (MEX:FLGT), the current Beta is 0.3621 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fulgent Genetics (MEX:FLGT) Overvalued in 2026?

Based on GuruFocus' analysis, Fulgent Genetics stock appears to be undervalued. The current stock price of MXN312.50 is trading 57.2% below its estimated GF Value™ of MXN729.64. GuruFocus considers Fulgent Genetics to be Possible Value Trap.

Key valuation signals for MEX:FLGT:

  • Beta: 0.3621
  • GF Value™: MXN729.64 vs. price of MXN312.50 (57.2% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the MEX:FLGT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fulgent Genetics Business Description

Other Exchanges FLGT:USA
Address 4399 Santa Anita Avenue, El Monte, CA, USA, 91731
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
64GF Score

Get the complete analysis for MEX:FLGT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN312.50
Price
MXN729.64
GF Value